SuperworthOrthofix Medical profit margin OFIX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −7.4%
- Operating margin, 12 months
- −4.7%
- Net margin on a year earlier
- +7.9 pts
- Peer median
- 7.8%
Over the twelve months to Jun 30, 2026, Orthofix Medical kept −7.4% of its revenue as net profit, with an operating margin of −4.7% and a gross margin of 71.3%.
Five years earlier its net margin was −1.8%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −11.2% | −9.9% | 68.8% |
| FY2024 | −15.8% | −10.6% | 68.3% |
| FY2023 | −20.3% | −18.6% | 65.1% |
| FY2022 | −4.3% | −2.9% | 73.2% |
| FY2021 | −8.3% | −1.8% | 75.3% |
| FY2020 | 0.6% | −1.5% | 74.9% |
| FY2019 | −6.2% | −4.1% | 78.1% |
| FY2018 | 3.0% | 6.6% | 78.7% |
| FY2017 | 1.4% | 9.4% | 78.6% |
| FY2016 | 0.7% | 5.1% | 78.6% |
| FY2015 | −0.7% | 2.3% | 78.2% |
| FY2014 | −2.1% | 4.3% | 75.4% |
| FY2013 | −7.2% | −2.8% | 73.1% |
| FY2012 | 9.7% | 17.0% | 77.1% |
| FY2011 | −0.2% | 1.3% | 78.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −7.4% | +7.9 pts | −4.7% | |
| Q1 FY26 | −7.3% | +10.5 pts | −5.7% | |
| Q4 FY25 | −11.2% | +4.5 pts | −9.9% | |
| Q3 FY25 | −14.6% | +0.6 pts | −11.4% | |
| Q2 FY25 | −15.3% | +0.3 pts | −11.8% | |
| Q1 FY25 | −17.8% | −1.1 pts | −12.9% | |
| Q4 FY24 | −15.8% | +4.5 pts | −10.6% | |
| Q3 FY24 | −15.2% | +5.2 pts | −11.7% | |
| Q2 FY24 | −15.6% | +4.1 pts | −12.6% | |
| Q1 FY24 | −16.6% | −2.2 pts | −14.3% | |
| Q4 FY23 | −20.3% | −16.0 pts | −18.6% | |
| Q3 FY23 | −20.4% | −10.6 pts | −19.7% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orthofix Medical's size, closest first, today.
| Company | Profit margin |
|---|---|
| OFIXOrthofix Medical | −7.4% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| INFUInfuSystem | 6.0% |
| UTMDUtah Medical Products | 29.0% |
| MOVMovado | 6.0% |
| PDEXPro DEX | 17.6% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| BVSBioventus | 9.4% |
| Peer median | 7.8% |
Where Orthofix Medical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Orthofix Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.